Modivcare and Tenovi Partner to Advance Respiratory Care, Lower Hospitalizations, and Cut Costs with Adherium’s Hailie® Smart Inhalers
17 Octubre 2024 - 6:30AM
Business Wire
Modivcare Inc., a leading technology-enabled healthcare services
company that provides a platform of integrated supportive care
solutions, through its wholly owned subsidiaries, Valued
Relationships, Inc. (VRI) and Higi Care, LLC (collectively for
purposes of this press release, “Modivcare”), have partnered with
Tenovi, an innovator in cellular-connected remote monitoring
solutions, to deliver Adherium’s Hailie® Smart inhalers for
enhanced care of patients with chronic respiratory diseases.
The collaboration combines Tenovi’s Cellular Gateway and
Modivcare’s chronic condition management service offerings to
create a cost-effective ecosystem that helps healthcare providers
deliver a clinically proven medication adherence solution to
optimally manage patients with difficult-to-treat and severe asthma
and reduce the total cost of care.
“Our partnership with Modivcare enables Tenovi to extend our
remote monitoring capabilities into payor programs, where improving
quality of care and reducing overall respiratory care costs is
critical,” said Iftah Mashav, Chief Growth Officer at Tenovi.
“Modivcare’s chronic condition management service offerings
combined with Tenovi’s cellular-connected technology allows
healthcare providers to connect multiple remote monitoring and
therapeutic monitoring devices seamlessly.”
“We are excited about this collaboration as it allows Modivcare
to enhance the way we support members with chronic respiratory
conditions by integrating advanced technological capabilities with
personalized care,” said L. Heath Sampson, President and Chief
Executive Officer at Modivcare. “By combining Modivcare’s chronic
condition management service offerings with Tenovi’s innovative
connectivity solutions, we are able to deliver a more seamless,
efficient approach to medication adherence for asthma, ultimately
leading to improved health outcomes and reduced healthcare
costs.”
Medication adherence is a major challenge, with 50 percent of
patients with chronic illnesses not taking their medication as
prescribed.1 Adherium’s Hailie® Smart Inhalers directly address
this issue by tracking adherence and reducing exacerbations in
asthma and COPD patients. This results in better outcomes, fewer
hospitalizations, and improved patient quality of life.
Tenovi’s Cellular Gateway simplifies the care delivery process
for care management companies and healthcare providers by
consolidating data from multiple connected medical devices and
securely transmitting it to the Tenovi Cloud, reducing the need for
high-cost individual cellular connections for each device and
eliminating the need for a personal or provided mobile device. This
scalable solution boosts efficiency and lowers costs across the
board. In addition, Tenovi’s device ecosystem empowers programs to
lean on existing Durable Medical Equipment, DME,
strategies/practices while simplifying connectivity and data
strategies.
About Modivcare
Modivcare Inc. ("Modivcare" or the "Company") is a
technology-enabled healthcare services company that provides a
suite of integrated supportive care solutions for public and
private payors and their members. The Company’s value-based
solutions address social determinants of health (SDoH), enable
greater access to care, reduce costs, and improve outcomes.
Modivcare is a leading provider of non-emergency medical
transportation (NEMT), personal care services, and remote patient
monitoring solutions. To learn more about Modivcare, please visit
www.modivcare.com.
About Tenovi
Tenovi is a data aggregation and automation platform that
connects medical device manufacturers with remote patient
monitoring companies. It provides over 30 medical device point
solutions that connect with its proprietary Cellular Gateway to
automate the transfer of patient vitals. Tenovi's API-driven
fulfillment and automation services enable seamless deployment of
remote patient and therapeutic monitoring programs. For more
information, visit tenovi.com.
1 World Health Organization. (2003). Adherence to long-term
therapies: evidence for action. World Health Organization.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20241017658516/en/
Media: Janice Murphy jmurphy@tenovi.com 714-388-6695